Why Dynavax Technologies Stock Is Soaring Today
Published
A COVID-19 vaccine candidate that employs the company's adjuvant technology produced positive clinical trial results.
Full ArticlePublished
A COVID-19 vaccine candidate that employs the company's adjuvant technology produced positive clinical trial results.
Full ArticleA lost supply agreement for a partner's COVID-19 vaccine is hurting the biotech's shares today.